Intensive Blood-Pressure Control in Hypertensive Chronic Kidney Disease
New England Journal of Medicine2010Vol. 363(10), pp. 918–929
Citations Over TimeTop 1% of 2010 papers
Lawrence J. Appel, Jackson T. Wright, Tom Greene, Lawrence Y. Agodoa, Brad C. Astor, George L. Bakris, W. H. Cleveland, Jeanne Charleston, Gabriel Contreras, Marquetta Faulkner, Francis B. Gabbai, Jennifer Gassman, Lee A. Hebert, Kenneth Jamerson, Joel D. Kopple, John W. Kusek, James P. Lash, Janice P. Lea, Julia B. Lewis, Michael S. Lipkowitz, Shaul G. Massry, Edgar R. Miller, Keith C. Norris, Robert A. Phillips, Velvie A. Pogue, Otelio S. Randall, Stephen G. Rostand, Miroslaw Smogorzewski, Robert D. Toto, Xuelei Wang
Abstract
In overall analyses, intensive blood-pressure control had no effect on kidney disease progression. However, there may be differential effects of intensive blood-pressure control in patients with and those without baseline proteinuria. (Funded by the National Institute of Diabetes and Digestive and Kidney Diseases, the National Center on Minority Health and Health Disparities, and others.)
Related Papers
- → Cardiovascular disease and the kidney(2002)49 cited
- → Peripherally inserted central catheters (PICC) use in patients with chronic kidney disease (CKD)(2020)1 cited
- → Is Cessation of Anti-Platelet Therapy Prior to Elective Outpatient Hernia Surgery Necessary? An Observational Study of 565 Patients(2017)
- → TCT-370 Clinical Outcomes of Subjects With and Without Prior Gastrointestinal Bleeding in the Amplatzer Amulet Observational Study(2019)